Related by context. All words. (Click for frequent words.) 71 Demonstrates Efficacy 70 Single Dose 70 Progressive Multifocal Leukoencephalopathy 70 Fungal Infections 70 Pneumococcal Vaccine 70 Nebulized 70 Combination Therapy 70 Rotavirus Vaccine 70 Infected Patients 70 Patients Receiving 69 Adjuvant Chemotherapy 69 Capecitabine 69 Unfractionated Heparin 69 Oral Fingolimod 69 Rheumatoid Arthritis Patients 69 Chronic Hepatitis B 69 Investigational Agent 69 Treating Chronic 68 Venous Thromboembolism 68 Monotherapy 68 Complicated Skin 68 Pediatric Patients 68 Prolongs Survival 68 Metastatic Prostate Cancer 68 Prophylactic 68 Immune Responses 68 Invasive Fungal Infections 68 Pulmonary Arterial Hypertension 68 JAK Inhibitor 68 Disease Progression 68 Community Acquired Pneumonia 68 Investigational Treatment 68 Postmenopausal Osteoporosis 68 Patients Treated 68 Improves Outcomes 68 Double Blind Randomized 68 Well Tolerated 68 Combination Treatment 68 Chronic Sinusitis 68 Tigecycline 68 Advanced Prostate Cancer 68 Peginterferon 67 Peginterferon Alfa 2a 67 Anthracycline 67 Shows Efficacy 67 Elderly Patients 67 Protease Inhibitor 67 Corticosteroid 67 HCV Genotype 67 Fracture Risk 67 Hepatitis B Virus 67 Pooled Analysis 67 Severe Sepsis 67 Immunosuppression 67 Genital Herpes 67 ritonavir boosted 67 Phase III Clinical Trial 67 Antitumor Activity 67 Immunosuppressant 67 Daptomycin 67 Statistically Significant 67 Cardiovascular Events 67 Hepatocellular Carcinoma 67 Prophylactic Treatment 67 Thromboembolism 67 See CLINICAL PHARMACOLOGY 67 Adjuvant Treatment 67 Fluorouracil 67 Nilotinib 67 Allogeneic 67 Seasonal Influenza Vaccine 67 suppressive therapy 67 Adefovir 67 Treatment Naive Patients 67 Autologous Stem Cell Transplantation 67 Allergic Rhinitis 67 Regimens 67 Hepatitis C Patients 67 Antitumor 66 Fondaparinux 66 Vaccine Candidate 66 Severe Asthma 66 Controlled Trial 66 Anticoagulant 66 Localized Prostate Cancer 66 Tiotropium 66 Efficacious 66 Placebo Controlled Trial 66 Relapsing Multiple Sclerosis 66 Chronic Renal Failure 66 Chronic Hepatitis C 66 Postmenopausal Women 66 Clinical Efficacy 66 Kidney Transplant Recipients 66 Pneumococcal Conjugate Vaccine 66 Melphalan 66 Subcutaneous 66 Appears Safe 66 Ranolazine 66 Advanced Melanoma 66 Antifungal 66 Antiretroviral Therapy 66 Lung Injury 66 Heart Failure Patients 66 Decitabine 66 Adjuvant Therapy 66 Newly Diagnosed Multiple Myeloma 66 Efficacy Trial 66 Skeletal Muscle 66 Treated Patients 66 Angioedema 66 trimethoprim sulfamethoxazole 66 Androgen Deprivation Therapy 66 Liver Failure 66 Risedronate 66 Patients Undergoing 66 Resistant Hypertension 66 Placebo Controlled Study 66 Telbivudine 66 Investigational Drug 66 Colorectal Cancer Patients 66 Epoetin Alfa 65 Improves Survival 65 ACE Inhibitors 65 Clinical Outcome 65 Statin Therapy 65 Haemophilus b Conjugate 65 Bivalirudin 65 Genital Warts 65 Critically Ill Patients 65 Advanced Pancreatic Cancer 65 Clostridium difficile Infection 65 Pafuramidine 65 Bloodstream Infections 65 Metastatic Colorectal Cancer 65 Bacterial Vaginosis 65 Plus Ribavirin 65 Corticosteroids 65 Contraindications 65 Pegylated Liposomal Doxorubicin 65 Malignancies 65 Viral Suppression 65 Protease Inhibitors 65 NDA Submission 65 Naive Patients 65 Acute Ischemic Stroke 65 Cardiovascular Outcomes 65 Inhaled Corticosteroids 65 Drug Resistant 65 Septic Shock 65 Vaginal Gel 65 Paraplatin ® 65 Phase 2b Study 65 Tumor Response 65 Phase 2b Clinical Trial 65 Smallpox Vaccine 65 Diabetic Patients 65 Controlled Study 65 Combination Vaccine 65 prophylaxis 65 Parenteral Nutrition 65 Overactive Bladder 65 Patients Treated With 65 Aliskiren 65 Cytotoxicity 65 Symptom Relief 65 Transdermal Patch 65 Pharmacokinetics PK 65 Unresectable 65 Phase IIb Trial 65 Hepatitis C Genotype 65 Meets Primary Endpoint 65 Pegylated Interferon 65 alfa 2a 65 Preterm Delivery 65 Long Term Efficacy 65 Metastatic Melanoma 65 Hepatitis C Virus 65 Antiplatelet 65 Gastric Cancer 65 5 Fluorouracil 65 Topical Treatment 65 Kidney Function 65 Meta Analysis 65 Zoledronic Acid 65 Inactivated 65 Cardiotoxicity 65 Cyclophosphamide 65 Mycophenolate Mofetil 65 Invasive Breast Cancer 65 FASLODEX 65 antibiotic prophylaxis 65 Improved Survival 65 ganciclovir 65 Natalizumab 65 Respiratory Infections 65 Is Well Tolerated 65 Antiviral Activity 65 Phase III Trial 65 Intravesical 65 Diabetic Neuropathy 65 Combo Therapy 64 Thrombus 64 Urinary Tract Infections 64 Neoadjuvant 64 Novel Antibiotic 64 Asymptomatic 64 Aortic Stenosis 64 Pegylated 64 Colorectal Adenomas 64 Therapeutic Efficacy 64 Darunavir 64 Celecoxib 64 Osteoporosis Treatment 64 Atopic Dermatitis 64 Improve Outcomes 64 Breast Cancer Recurrence 64 Therapeutic Vaccine 64 Lymphoid 64 postexposure prophylaxis 64 Myeloma Patients 64 Oral Mucositis 64 Estrogen Therapy 64 Liver Metastases 64 Hospital Acquired Pneumonia 64 Intravenous Formulation 64 Survival Benefit 64 Multiple Myeloma Patients 64 Drug Candidate 64 Telithromycin 64 Renal Anemia 64 Antiviral Therapy 64 Antiviral Drugs 64 Demonstrates Potent 64 Fixed Dose 64 Low Dose 64 abacavir Ziagen 64 INTEGRILIN R 64 Dengue Virus 64 Bacteremia 64 Beta Blocker 64 Thromboembolic 64 cidofovir 64 Follicular Lymphoma 64 HCV Protease Inhibitor 64 Lubiprostone 64 Inflammatory Markers 64 Extended Release 64 Isoniazid 64 BARACLUDE ® 64 pyrazinamide 64 Proves Effective 64 Coronary Angiography 64 Treatment Regimen 64 Drug Combo 64 Colorectal Screening 64 Gout Drug 64 Pharmacokinetic Study 64 IND Application 64 Interferon Beta 64 Intranasal 64 Improve Survival 64 Viral Load 64 Clinical Trial Results 64 Chemotherapy Induced Nausea 64 Immune Globulin 64 Postherpetic Neuralgia 64 Premature Infants 64 Cyclosporine 64 invasive aspergillosis 64 Rotavirus Vaccines 64 Salmeterol 64 Drug Regimen 64 Non Responders 64 INFERGEN 64 Glatiramer Acetate 64 Montelukast 64 Renal Function 64 Methotrexate 64 Postmenopausal 64 Tacrolimus 64 Randomized Double Blind 64 Otitis Media 63 Neoadjuvant Chemotherapy 63 Demonstrates Positive 63 Intracerebral 63 Chemotherapy Induced 63 Anticoagulants 63 MRSA Infections 63 Cethromycin 63 Gram Positive 63 Tuberculosis Vaccine 63 Progenitor Cells 63 Prostate Cancer Patients 63 Moxifloxacin 63 Diabetic Foot Ulcer 63 Experimental Vaccine 63 Taxane 63 Preclinical Data 63 Hormone Receptor Positive 63 Radical Prostatectomy 63 Levofloxacin 63 Adverse Event 63 alpha 2a 63 Virus Infection 63 Infliximab 63 Allergic Asthma 63 Acute Migraine 63 Respiratory Virus 63 lamivudine 3TC 63 Enoxaparin 63 Phase 2b Trial 63 efavirenz EFV 63 gonococcal infections 63 Relapsing Remitting Multiple Sclerosis 63 nucleoside analog 63 Anti Tumor Activity 63 Dasatinib 63 Adjuvant 63 Immunogenicity 63 tenofovir Viread 63 Radiofrequency Ablation RFA 63 antimicrobial prophylaxis 63 Anti TNF 63 Kidney Transplant Patients 63 HDAC Inhibitor 63 Clinical Trial Evaluating 63 Randomized Study 63 Chemoradiation 63 Interferon Alfa 63 Bacterial Infections 63 Non Alcoholic Fatty 63 Irinotecan 63 Helicobacter Pylori 63 ST Segment Elevation 63 Solid Tumors 63 Bronchodilator 63 Prospective Randomized 63 Thrombotic 63 Ribavirin 63 Investigational Compound 63 Hemolysis 63 Virologic 63 Renal Cell Carcinoma 63 Adjunctive 63 Dupuytren Contracture 63 Dose Escalation 63 piperacillin tazobactam 63 meropenem 63 administered subcutaneously 63 Vitro Activity 63 protease inhibitor PI 63 Antibiotic Use 63 Randomized Controlled Trial 63 Proven Effective 63 Fluticasone 63 Hepatitis B Vaccine 63 Replacement Therapy 63 Serious Infections 63 Double Blind Placebo 63 Knee Osteoarthritis 63 Hormone Refractory Prostate Cancer 63 Azathioprine 63 tipranavir 63 Leucovorin 63 Stress Incontinence 63 Novel Mechanism 63 Leukemias 63 Fast Track Status 63 Myelodysplastic Syndromes 63 Rifampin 63 Confirms Efficacy 63 Atypical Hemolytic Uremic Syndrome 63 Bevacizumab 63 Respiratory Syncytial Virus 63 Chronic Heart Failure 63 LYSTEDA 63 Tolerability 63 Nitazoxanide 63 Antibiotic Treatment 63 Helicobacter pylori eradication 63 Posaconazole 63 Influenza Vaccine 63 Antibiotic Resistant 63 ethambutol 63 Renal Impairment 63 Pandemic Influenza Vaccine 63 C1 Inhibitor 63 Seasonal Influenza 63 Nucleoside 63 Recombinant Human 63 TYGACIL 63 Cutaneous T 63 Radiation Induced 63 Adalimumab 63 Myocardial Ischemia 63 acyclovir Zovirax 63 Drug Shows Promise 63 Insulin Therapy 63 Drug Resistant TB 63 insulin glulisine 63 Node Positive 63 Itraconazole 63 Nosocomial 63 CLINICAL PHARMACOLOGY 63 Patients Suffering 63 unfractionated heparin UFH 63 Vaccine Protects Against 63 Treatment Experienced 63 Monoclonal Antibody 63 Endocarditis 63 Watchful Waiting 63 Seasonal Flu Vaccine 63 Tyrosine Kinase Inhibitor 63 Platinol ® 63 Malignant Melanoma 63 Immunoglobulin 63 Demonstrated Significant 63 Peginterferon Alfa 2b 63 Fingolimod 63 Immunotherapeutic 63 Streptococci 62 Parathyroid Hormone 62 Dialysis Patients 62 Alendronate 62 Unstable Angina 62 Acute Coronary Syndromes 62 Acute Pancreatitis 62 Multicenter Trial 62 Reduces Mortality 62 Systematic Review 62 Hematological Cancers 62 Chronic Myeloid Leukemia 62 Dendritic Cells 62 Begin Clinical Trials 62 Initiate Clinical Trial 62 Linezolid 62 Viral Infection 62 Immune Mediated 62 amprenavir 62 Tumor Growth 62 Soft Tissue Sarcoma 62 Treatment Reduces 62 Subtypes 62 Liver Injury 62 Study Evaluating 62 Shows Promising 62 Percutaneous Coronary Intervention 62 Glucocorticoid 62 Mouse Model 62 Potentially Fatal 62 Fibrinogen 62 Antiretrovirals 62 Treatment Naïve Patients 62 Plaque Psoriasis 62 Effectively Treats 62 MYCAMINE 62 ARIXTRA R 62 Shows Promise Against 62 Cytarabine 62 tigecycline 62 Fulvestrant 62 Clopidogrel 62 Chronic Prostatitis 62 voriconazole 62 Stem Cell Treatment 62 Migraine Pain 62 Hypertensive Patients 62 Surgical Procedures 62 nimodipine 62 Mg Uk 62 Therapy Shows Promise 62 Prostate Biopsy 62 nitrofurantoin 62 Rhinitis 62 Drug Prevents 62 Immunomodulatory 62 Autoimmune Diseases 62 Advanced Ovarian Cancer 62 Topical Gel 62 Cholesterol Lowering Drug 62 Previously Treated 62 Treatment Resistant 62 Neoplasms 62 Captopril 62 Bicalutamide 62 Microalbuminuria 62 Non Inferiority 62 Acute Otitis Media 62 Ischemic 62 G CSFs 62 Relapsed Refractory 62 HER2 Positive Breast Cancer 62 Antithrombin 62 Malignant Glioma 62 Test Detects 62 Orally Active 62 Live Attenuated Influenza Vaccine 62 Erlotinib 62 ara C 62 Hydroxyurea 62 von Willebrand Factor 62 Prostate Cancer Vaccine 62 Deep Venous Thrombosis 62 Study Showed 62 Commonly Used 62 Demonstrates Significant 62 Fewer Side Effects 62 Reduced Incidence 62 Bosutinib 62 Microplasmin 62 Universal Flu Vaccine 62 Osteoporosis Drug 62 Kidney Transplants 62 Epilepsy Drug 62 Carotid Endarterectomy 62 FDA Approvals 62 Intracerebral Hemorrhage 62 Refractory Hodgkin Lymphoma 62 II Clinical Trial 62 Respiratory Syncytial Virus RSV 62 Uterine Fibroid Embolization 62 Osteoporosis Drugs 62 Antimicrobial Activity 62 Pemetrexed 62 Chronic Constipation 62 Reduce Mortality 62 Lamivudine 62 Teriparatide 62 imipenem 62 tolterodine ER 62 Neonates 62 Faropenem 62 Radiofrequency Ablation 62 Pharmacologic 62 Disease Modifying 62 Pivotal Study 62 Previously Untreated 62 Treatment Naive HIV 62 APTIVUS 62 Hemodialysis Patients 62 Percutaneous Tibial Nerve Stimulation 62 Anti Inflammatory Drug 62 prucalopride 62 Receives Orphan Drug Designation 62 Benign Prostatic Hyperplasia 62 Phase III Trials 62 Post Operative 62 Secondary Hyperparathyroidism 62 Adjunctive Therapy 62 Budesonide 62 Anticoagulation 62 Hepatotoxicity 62 Adjuvanted 62 APTIVUS r 62 neutropenic patients 62 Catheter Associated 62 Antidepressant Drug 62 Adverse Effects 62 Interferon Gamma 62 Potent Anti 62 Methylprednisolone 62 Candidiasis 62 Bacterial Infection 62 Cognitive Impairment 62 Iron Deficiency 62 Malaria Vaccine 62 Antihistamine 62 Patency 62 Hypercholesterolemia 62 Shingles Vaccine 62 Anti Tumor 62 Metastases 62 miconazole 62 Organ Rejection 62 Antihypertensive 62 Fluconazole 62 Advanced Renal Cell 62 Breast Cancer Patients 62 bisoprolol 61 Gemcitabine 61 Sinus Infections 61 combination antiretroviral therapy 61 Tumor Progression 61 Macrolide 61 antibiotic azithromycin 61 Fludarabine 61 valacyclovir Valtrex 61 Castration Resistant Prostate Cancer 61 Viral Infections 61 Thiazolidinediones 61 Abciximab 61 Phase 2a Trial 61 invasive candidiasis 61 Chemokine Receptor 61 Platelet Function 61 ARIXTRA 61 Cytomegalovirus 61 Randomized Controlled Trials 61 Clinical Evaluation 61 systemic corticosteroids 61 Cilostazol 61 Lupus Drug 61 Mylan Receives Approval 61 Generalized Anxiety Disorder 61 Partial Onset Seizures 61 Hypotension 61 Enlarged Prostate 61 Lenalidomide 61 Positive Opinion 61 Pivotal Phase III 61 Enzastaurin 61 Antiplatelet Therapy 61 Lung Infections 61 RNAi Therapeutic 61 Tetanus Toxoids 61 Multicenter Randomized 61 Obese Patients 61 Juvenile Idiopathic Arthritis 61 Golimumab 61 Newly Diagnosed 61 Pain Relievers 61 Breast Cancers 61 Breast Cancer Treatment 61 Left Atrial 61 Human Monoclonal Antibody 61 ribavirin RBV 61 nelfinavir 61 Carcinoma 61 Increased Mortality 61 Exacerbation 61 Enzyme Replacement Therapy 61 Maribavir 61 Ischemic Stroke 61 Bladder Cancer 61 Adenoviral 61 Gonadotropin 61 Novel Oral 61 AZT zidovudine Retrovir 61 Cognitive Function 61 Diabetic Nephropathy 61 Inhaled Liposomal Ciprofloxacin 61 Eculizumab 61 Antibacterials 61 Staphylococcal 61 docetaxel Taxotere ® 61 Valsartan 61 Ozarelix 61 Anticancer Activity 61 Phase 2a Clinical Trial 61 Lymphocytic 61 proctitis 61 Formoterol 61 REYATAZ ® 61 nevirapine Viramune 61 Short Stature 61 zidovudine AZT 61 Gum Disease 61 Potent Antiviral Activity 61 Venous Thrombosis 61 Maleate 61 Restenosis 61 Bosentan 61 Low Doses 61 Treatment Regimens 61 Chronic HCV 61 Treatment Naive 61 severe oral mucositis 61 candidemia 61 atazanavir sulfate 61 Clinical Relevance 61 Blood Transfusions 61 Ziprasidone 61 mitomycin C 61 Beta Blockers 61 Randomised 61 Neuroprotective Effects 61 Left Ventricular 61 B Cell Lymphoma 61 Molecular Weight Heparin 61 Chronic Rhinosinusitis 61 Sustained Efficacy 61 Multidrug 61 Proton Pump Inhibitors 61 Receptor Antagonists 61 Late Breaker 61 Pharmacodynamics 61 First Patient Dosed 61 Antacids 61 quinolone antibiotics 61 Etanercept 61 Successfully Treated 61 Immune Tolerance 61 PREZISTA ritonavir 61 Zoledronic acid 61 Dalbavancin 61 Peptic Ulcer 61 Sustained Release 61 Reduced Risk 61 linezolid resistant 61 Peripheral Blood 61 Smallpox Vaccination 61 Bortezomib 61 rilonacept 61 Noxafil 61 Renal Artery 61 Vaccine Adjuvant 61 Synthetic Peptide 61 Regimen 61 Elevated Levels 61 Rimantadine 61 Infective 61 HER2 Positive 61 Lowers Risk 61 Significantly Improved 61 Breast Tumors 61 Nymox NX 61 Hematopoietic 61 Randomized Clinical Trial 61 Skin Lesions 61 polysaccharide vaccine 61 PEGylated anti 61 Pivotal Phase 61 Transplant Patients 61 Rectal Cancer 61 Antiretroviral 61 mycophenolate mofetil 61 DOXIL 61 Chronic Kidney 61 Renal Cancer 61 Bipolar Mania 61 amoxicillin clavulanate 61 Valopicitabine 61 fluvastatin 61 Influenza Virus 61 efalizumab 61 Phase IIa Clinical Trial 61 administered concomitantly 61 Insulin Glargine 61 leiomyomas 61 Functional Outcomes 61 gastrointestinal stromal tumors GIST 61 Novel Treatments 61 Intravenous immunoglobulin 61 Peripheral Arterial 61 Uric Acid 61 Toxicities 61 Lung Cancer Trial 61 Signaling Pathway 61 Acute Attacks 61 Lung Cancer Patients 61 Hospitalized Patients 61 Secretory 61 Meningitis Vaccine 61 Lupus Nephritis 61 relapsed MM 61 betamethasone 61 Phase III Pivotal Trial 61 Nesiritide 61 Cardiovascular Disease Risk 61 Cancer Treatments 61 Ketorolac 61 Radioimmunotherapy 61 Sevelamer 61 Betaferon R 61 #mg Tablets [002] 61 Tyrosine Kinase Inhibitors 61 Treating Heart Failure 61 administered intramuscularly 61 Pamidronate 61 Sipuleucel T 61 BAL# [002] 61 Traficet EN 61 Stem Cell Transplants 61 Portal Hypertension 61 Iron Deficiency Anemia 61 Epidermal Growth Factor Receptor 61 corticosteroid therapy 61 VP# [004] 61 Demonstrate Significant 61 Cutaneous 61 Cell Lymphoma CTCL 61 Pandemic Flu Vaccine 61 toxoid 61 Tumor Cell 61 Orthostatic Hypotension 61 Fixed Dose Combination 61 Oropharyngeal Candidiasis 61 Decompensated 61 ORENCIA ® 61 Dual Antiplatelet Therapy 61 Effective Treatments 61 anagrelide 61 Oral Formulation 61 Metronidazole 60 Data Suggest 60 Fluoroquinolones 60 Phase IIb Clinical Trial 60 Therapy Improves 60 cefuroxime 60 Migraine Treatment 60 Contrast Agents 60 immunocompetent patients 60 Darbepoetin Alfa 60 LOVENOX R 60 Subgroup Analysis 60 Hepatitis C Infection 60 Hepatic 60 Keratitis 60 darunavir r 60 Kinoid 60 Multicenter Study 60 Long Term Outcomes 60 urticaria hives 60 rFVIIa 60 Diarrheal 60 Oral Cladribine 60 Therapy Reduces 60 Vancomycin Resistant 60 Endovascular Treatment 60 Mitomycin C 60 Advanced Colorectal Cancer 60 Idiopathic Thrombocytopenic Purpura ITP 60 Brain Aneurysms 60 CMV infection 60 Novel Compound 60 Inhaled Nitric Oxide 60 Tenofovir Disoproxil Fumarate 60 dual endothelin receptor antagonist 60 Nicotine Vaccine 60 Acute Liver Failure 60 medroxyprogesterone acetate 60 Raltegravir 60 Platelet Inhibition 60 ergot derivatives 60 adefovir dipivoxil 60 TDF FTC 60 Conjugate Vaccine 60 ribavirin USP 60 trivalent vaccines 60 Beta Amyloid 60 Clinical Outcomes 60 Dosing Regimen 60 Oral Insulin 60 Highly Active Antiretroviral 60 Cold Sores 60 Transdermal Delivery 60 PegIFN RBV 60 Neulasta ® 60 primaquine 60 Migraine Headaches 60 Minimally Invasive Treatment 60 Fluticasone Propionate 60 PEGASYS ® 60 MEK Inhibitor 60 Initiates Clinical Trial 60 Vaccine Shows Promise 60 Non Alcoholic Steatohepatitis 60 Hair Follicle 60 pyrimethamine 60 5mg/kg 60 Relapsed Multiple Myeloma 60 Irritable Bowel 60 Higher Doses 60 ZYVOX 60 Reduces Risk 60 Prostatic 60 Prevent Stroke 60 Mg Usa 60 epoetin alpha 60 Epratuzumab 60 Acute Renal Failure 60 Embolization 60 Anthrax Vaccine 60 severe neutropenia 60 Acute Heart Failure 60 Radiation Exposure 60 Acute Kidney 60 Stent Thrombosis 60 canakinumab 60 Circulating Tumor Cells 60 Slow Progression 60 Metabolic Efficiency 60 Copegus ribavirin 60 Kidney Failure 60 CIMZIA TM 60 Didanosine 60 Chronic Pelvic Pain 60 NAVISTAR R 60 cytomegalovirus infection 60 Tumor Targeting 60 ß blockers 60 Immunogenic 60 PROCRIT R 60 Hsp# Inhibitor 60 H2 blockers 60 thromboprophylaxis 60 Polymorphisms 60 Humanized Anti 60 Conjugate 60 Decompensated Heart Failure 60 Novel Therapeutic 60 Artesunate 60 TNF Blockers 60 HBeAg negative 60 Prolongs Life 60 Cellular Immunotherapy 60 Myelodysplastic Syndrome MDS 60 Yeast Infections 60 hydroxocobalamin 60 Extended Release Formulation 60 Mesalamine 60 Chemotherapeutic Agents 60 Metabolic Disorder 60 Dose Escalation Study 60 Cervical Dysplasia 60 Diabetic Foot Ulcers 60 Hormone Therapy 60 Aggressive Prostate Cancer 60 Abacavir 60 Tetracycline 60 Cocaine Addiction 60 Bone Metastases 60 ARCOXIA 60 Metastatic Disease 60 Genes Linked 60 Delayed Graft Function 60 mycophenolate mofetil MMF 60 Hyperkalemia 60 Randomized Double Blind Placebo 60 exotoxin 60 headache abdominal pain 60 amikacin 60 Lung Cancer Survival 60 Oxaliplatin 60 Sustained Virologic Response 60 griseofulvin 60 Randomised Trial 60 Bone Mineral Density 60 Hip Fractures 60 Hematologic 60 Glycemic Control 60 Streptococcus Pneumoniae 60 Carotid Stenting 60 Poster Presentations 60 Shown Effective 60 Receives Positive Opinion 60 Expanded Indication 60 Inoculation 60 R entecavir 60 busulfan 60 Novel Inhibitor 60 Catheter Ablation 60 nicardipine 60 FDA Accepts 60 Phase III Clinical Trials 60 Seasonal Allergic Rhinitis 60 complement inhibitor eculizumab 60 Lymphoma Patients 60 Increased Risk 60 TAXOTERE R 60 Gastritis 60 chemoprophylaxis 60 abacavir lamivudine 60 Fibromyalgia Pain 60 Genotypes 60 Depressive Symptoms 60 Azacitidine 60 ZIAGEN 60 Recurrent Breast Cancer 60 PEG IFN 60 Epithelial 60 MAXALT 60 Insulin Resistance 60 Metastatic Renal Cell Carcinoma 60 intranasal corticosteroid 60 FUSILEV enhances 60 Chronic Lymphocytic Leukemia 60 Retinal Vein Occlusion 60 Dosage Form 60 Stomach Cancer 60 Neutralizing Antibodies 60 Subtype 60 Postmenopausal Hormone Therapy 60 tipranavir ritonavir 60 polysaccharide vaccines 60 Bare Metal Stent 60 Antifungals 60 ug kg 60 Prospective Randomized Trial 60 Peginterferon alfa 2b 60 acute respiratory tract infections 60 IIa Clinical Trial 60 Etravirine 60 HPV Vaccine Gardasil 60 Eltrombopag 60 Emerging Therapies 60 Ecallantide 60 ceftazidime